Central Garden (CENT) Surpasses Q3 Earnings Estimates

Central Garden (CENT) reported Q3 earnings of $1.56 per share, significantly surpassing the Zacks Consensus Estimate of $1.34 and marking its fourth consecutive quarterly EPS beat. However, the company's revenues of $960.91 million missed consensus estimates by 2.66% and declined year-over-year. Despite underperforming the S&P 500 year-to-date, Central Garden currently holds a Zacks Rank #1 (Strong Buy) based on favorable estimate revisions, suggesting potential near-term market outperformance, with future stock movement contingent on management's commentary during the earnings call.

Analysis

Central Garden & Pet Company (CENT) delivered a mixed but noteworthy Q3 2025 performance, characterized by strong profitability that overshadowed top-line weakness. The company reported quarterly earnings of $1.56 per share, decisively beating the Zacks Consensus Estimate of $1.34 by 16.42% and improving upon the $1.32 per share from the prior-year period. This marks the fourth consecutive quarter of surpassing EPS estimates, signaling effective cost management or a favorable product mix. However, this bottom-line strength contrasts sharply with revenues of $960.91 million, which not only missed consensus by 2.66% but also represented a decline from the $996.35 million recorded a year ago. This is the third time in four quarters the company has missed revenue estimates, raising concerns about underlying demand in its pet and garden markets. Despite the stock's year-to-date underperformance against the S&P 500 (2.1% vs 7.1% gain), a favorable pre-earnings estimate revision trend resulted in a Zacks Rank #1 (Strong Buy), suggesting analysts anticipated positive momentum. The company's future trajectory will now heavily depend on management's commentary regarding the sustainability of margins and the outlook for revenue growth.

Key Decisions for Investors

• Investors should closely analyze management's earnings call commentary to understand the drivers behind the significant earnings beat in the face of declining year-over-year revenue, focusing on margin sustainability and future top-line guidance.
• Given the stock's year-to-date underperformance and the strong Zacks Rank #1, a positive outlook from management could present a buying opportunity, as the market may have already priced in some of the revenue weakness.
• It is critical to monitor for any post-earnings revisions to consensus estimates, as the persistent revenue misses pose a key risk that could challenge the current bullish analyst rating and signal weakening fundamentals.